How risky is it to use e-cigarettes? Smokers’ beliefs about their health risks from using novel and traditional tobacco products by Pepper, Jessica K. et al.
How risky is it to use e-cigarettes? Smokers’ beliefs about their 
health risks from using novel and traditional tobacco products
Jessica K. Pepper,
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. 
Department of Health Behavior, Gillings School of Global Public Health, University of North 
Carolina, Chapel Hill, NC 27599-7440, USA
Sherry L. Emery,
Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, IL, USA
Kurt M. Ribisl,
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. 
Department of Health Behavior, Gillings School of Global Public Health, University of North 
Carolina, Chapel Hill, NC 27599-7440, USA
Christine M. Rini, and
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. 
Department of Health Behavior, Gillings School of Global Public Health, University of North 
Carolina, Chapel Hill, NC 27599-7440, USA
Noel T. Brewer
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. 
Department of Health Behavior, Gillings School of Global Public Health, University of North 
Carolina, Chapel Hill, NC 27599-7440, USA
Jessica K. Pepper: jkadis@unc.edu; Sherry L. Emery: slemery@uic.edu; Kurt M. Ribisl: kurt_ribisl@unc.edu; Christine M. 
Rini: rini@email.unc.edu; Noel T. Brewer: ntb@unc.edu
Abstract
We sought to understand smokers’ perceived likelihood of health problems from using cigarettes 
and four non-cigarette tobacco products (NCTPs: e-cigarettes, snus, dissolvable tobacco, and 
smokeless tobacco). A US national sample of 6,607 adult smokers completed an online survey in 
March 2013. Participants viewed e-cigarette use as less likely to cause lung cancer, oral cancer, or 
heart disease compared to smoking regular cigarettes (all p < .001). This finding was robust for all 
demographic groups. Participants viewed using NCTPs other than e-cigarettes as more likely to 
cause oral cancer than smoking cigarettes but less likely to cause lung cancer. The dramatic 
increase in e-cigarette use may be due in part to the belief that they are less risky to use than 
Correspondence to: Jessica K. Pepper, jkadis@unc.edu.
Conflict of interest
Drs. Jessica Pepper, Sherry Emery, Kurt Ribisl, Christine Rini, and Noel Brewer declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation 
(institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all 
participants for being included in the study.
HHS Public Access
Author manuscript
J Behav Med. Author manuscript; available in PMC 2015 October 01.
Published in final edited form as:













cigarettes, unlike the other NCTPs. Future research should examine trajectories in perceived 
likelihood of harm from e-cigarette use and whether they affect regular and electronic cigarette 
use.
Keywords
Electronic cigarettes; Electronic nicotine delivery systems; Tobacco products; Risk perceptions; 
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Introduction
Traditional cigarettes remain the most popular tobacco product in the US; 18 % of US adults 
were current smokers in 2012 (Centers for Disease Control and Prevention, 2014). However, 
many other non-cigarette tobacco products (NCTPs) are currently available in the US 
market, including electronic cigarettes (e-cigarettes), snus, dissolvable tobacco, and 
traditional smokeless tobacco. E-cigarettes are battery-powered devices that produce vapor 
by heating a solution containing nicotine, humectants, and flavoring, although non-nicotine 
versions are available. Snus are packets of moist tobacco that users place between their 
gums and cheeks. Dissolvable tobacco typically comes in the form of sticks, strips, or orbs 
(aspirin-sized tablets of tobacco).
These non-cigarette tobacco products vary in their popularity. The percentage of US adults 
who have tried e-cigarettes in the past (“ever users”) rose from 1 % in 2009 (Regan et al., 
2013) to 15 % in 2013 (Pepper et al., 2014), and rates are higher among smokers. Half of 
current smokers in a 2013 nationally representative US survey had ever tried e-cigarettes, 
and 80 % of e-cigarette ever users also smoked cigarettes (Emery, 2013). In contrast, about 
5 % of US adults surveyed in 2012–2013 had ever tried snus, and fewer than 1 % had ever 
tried dissolvable tobacco (Agaku et al., 2014). More people in the US (18 %) have tried 
traditional smokeless tobacco than have tried e-cigarettes, snus, and dissolvable tobacco 
(Substance Abuse and Mental Health Services Administration, 2012). While rates of 
cigarette smoking among US adults have declined, rates of use of non-cigarette tobacco 
products, especially e-cigarettes, have increased (Centers for Disease Control and 
Prevention, 2014; Lee et al., 2014; Pepper & Brewer, 2014; U.S. Department of Health and 
Human Services, 2014).
Because products like e-cigarettes, snus, dissolvable tobacco, and traditional smokeless 
tobacco do not rely on combustion, they do not produce many of the same harmful 
chemicals and particles that regular cigarettes do and are therefore considered by scientists 
to be less dangerous (Hecht, 2003; Levy et al., 2004; Royal College of Physicians, 2007). 
However, non-combustible tobacco products are not entirely without potential harm. For 
example, certain models of e-cigarettes have been found to contain carcinogenic tobacco-
specific nitrosamines and other harmful constituents (Orr, 2014), and newer models of e-
cigarettes with higher voltage batteries can produce formaldehyde at levels equivalent to 
combustible cigarettes (Kosmider et al., 2014). Some researchers are also concerned about 
the long-term impact of inhaling humectants like propylene glycol (Varughese et al., 2005).
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The degree to which the public believes that NCTPs are less harmful than regular cigarettes 
could affect the prevalence of their use. Expectancy value theories like the Health Belief 
Model (Rosenstock, 1974), as well as past studies examining a variety of behaviors such as 
vaccination (Brewer et al., 2007) and cancer screening (Moser et al., 2007), suggest that 
perceived risk can motivate health behavior. Research shows that these beliefs can affect 
smoking behavior, although not consistently. For example, concern about the health 
consequences of smoking motivates many smokers to try to quit (Costello et al., 2012), and 
some smokers switched to “light” cigarettes because they believed these were healthier than 
non-light cigarettes (Cummings et al., 2004). However, across multiple prospective studies, 
the stated reason for wanting to quit smoking (i.e., health concerns versus other concerns) 
was rarely related to success in quitting (McCaul et al., 2006). Thus, we need to understand 
whether smokers perceive NCTPs to be less harmful than cigarettes and, as a result, use 
them more often.
We sought to understand how US adult smokers perceived the risks of using cigarettes and 
NCTPs. We focused on smokers because they are more likely than non-smokers to use 
NCTPs. First, we hypothesized that smokers would view e-cigarettes as less likely to cause 
health problems than cigarettes (Hypothesis 1). Consistent with Rogers’ diffusion of 
innovation model (Rogers, 2003), smokers may see a novel product (e-cigarettes) as an 
improved replacement for a traditional product (cigarettes) and thus would see the latter as 
riskier to use. Widespread e-cigarette advertising (Duke et al., 2014; Grana & Ling, 2014; 
Kim et al., 2014; Pepper et al., 2014) might introduce or reinforce beliefs about e-cigarettes 
being less harmful than cigarettes. We also hypothesized that smokers would see cigarettes 
as more likely to cause lung cancer than smokeless tobacco, snus, and dissolvable tobacco, 
but less likely to cause oral cancer (Hypothesis 2). Our reasoning was that beliefs about a 
tobacco product’s health risks can depend in part on how it comes into contact with the 
user’s body (Choi et al., 2012). Users place smokeless tobacco, snus, and dissolvable 
tobacco directly against the cheeks, tongue, or gums and therefore are likely to expect those 
products to cause cancer in those tissues. If smokers understood the central role of 
combustion in causing harm (Alexander, 2013), they would instead view all combustible 
products (not just e-cigarettes, but also smokeless tobacco, snus, and dissolvable tobacco) as 
less likely to cause all three of the health problems. In addition to testing these hypotheses, 
we conducted exploratory analyses comparing e-cigarettes to the alternative NCTPs.
Methods
Sample
The Tobacco Control in a Rapidly Changing Media Environment (TCME) project gathered 
data from a national sample of 17,522 US adults (6,607 current smokers, 4,160 former 
smokers, and 6,755 never smokers). The TCME survey, conducted online in March 2013, 
assessed recall of and searching for tobacco-related information, as well as the relationship 
between that information and tobacco use behaviors, beliefs, and attitudes. The majority of 
participants (75 %) were recruited from KnowledgePanel, a nationally representative online 
survey panel that recruits participants through random-digit dialing, supplemented by 
address-based sampling to capture cell phone-only households (GfK Knowledge Networks, 
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2014). Of 34,097 KnowledgePanel members sampled, 61 % (n = 20,907) completed the 
screening. Among eligible respondents (n = 13,531), 97 % (n = 13,144) completed the 
survey. Other participants were recruited from convenience samples of online market 
research panels, using quota sampling to match demographic characteristics of a nationally 
representative sample; response rate data from the market research panels are not available. 
For this study, we report data from current smokers (n = 6,607). Institutional review boards 
at the National Cancer Institute and the University of Illinois at Chicago approved the study.
Measures
Perceived health risks
Smokers responded to an item about the health risks of cigarettes: “How likely do you think 
it is that smoking cigarettes regularly would cause you to develop each of the following in 
the next 10 years? (If you’re not sure, please give us your best guess).” The health 
conditions were lung cancer, heart disease, and mouth or throat cancer (referred to as “oral 
cancer” hereafter). Respondents rated their likelihood of developing these health conditions 
on a 5-point response scale (“not at all likely” (coded as 1) to “extremely likely” (5)). We 
averaged the ratings of the likelihood of developing the three health conditions to create a 
scale (α = 0.95).
Survey software then randomly assigned smokers to receive another question about e-
cigarettes, snus, dissolvable tobacco (sticks, strip, or orbs), or traditional smokeless tobacco 
(moist snuff, dip, spit, chew). To conserve space on the survey, participants answered this 
item about only one product. Participants viewed a description of the product before 
responding to the item. The item read “Imagine that you stopped smoking regular cigarettes 
and only used [product]. How likely do you think it is that using [product] regularly would 
cause you to develop each of the following in the next 10 years? (If you’re not sure, please 
give us your best guess.)” The health conditions and response scale were the same as in the 
parallel item about regular cigarettes. We created a composite perceived risk measure for e-
cigarettes by averaging the ratings of the likelihood of developing the three health conditions 
for that product (α = 0.97). All of the risk perception items met the four “best practices” 
criteria for measuring risk perceptions as recommended by Brewer et al. (2004) because 
they focus on specific harms (lung cancer, heart disease, and oral cancer), identify the 
person at risk (the respondent), are contingent on behavior (regular use of the product), and 
designate a time frame (10 years).
Demographic characteristics and product use
The survey assessed participant demographics (gender, age, education, race/ethnicity, 
employment, region, and household income). It also assessed awareness of e-cigarettes and 
dissolvable tobacco (“Before today, had you ever heard of e-cigarettes?” and “Have you 
ever heard of dissolvable tobacco?”), as well as use of e-cigarettes (“Have you ever used an 
e-cigarette, even one puff?” and “Do you now use e-cigarettes some days, every day, or not 
at all?”) and dissolvable tobacco (“Have you ever used dissolvable tobacco products, such as 
Arriva, Stonewall, or Camel Orbs, Sticks, or Strips, even one time?”). We defined current 
use of e-cigarettes as using them every day or some days. The survey assessed quit 
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intentions with the item “Do you plan to quit smoking for good…?” (response options: in 
the next 7 days, in the next 30 days, in the next 6 months, in the next year, more than 1 year 
from now, or I do not plan to quit smoking for good). To assess understanding of item 
wording and ease of responding to survey items, we conducted cognitive interviews with 16 
people and then pre-tested the revised survey with 160 respondents. For all variables, we 
recoded missing scores (<0.5 % for each item) to the mean or mode of that item.
Data analysis
To address Hypothesis 1, we conducted within-subjects analyses, using paired t tests to 
compare the perceived risk of each of the three health problems for cigarettes versus e-
cigarettes. To examine the robustness of the findings comparing perceived risk for cigarettes 
and e-cigarettes, we repeated the t tests for demographic subgroups (e.g., only males, only 
smokers who intended to quit smoking in the next year) using the composite risk rating as 
well as each of the three specific risk ratings (lung cancer, heart disease, and oral cancer).
To address Hypothesis 2, we repeated the paired t tests to compare cigarettes to smokeless 
tobacco, snus, and dissolvable tobacco for each of the three health problems. For the 
exploratory analysis comparing e-cigarettes to the alternative NCTPs we conducted a 
between-subjects analysis, using linear regression to examine whether the perceived risk of 
developing lung cancer varied by NCTP type (e-cigarettes, smokeless tobacco, snus, and 
dissolvable tobacco). The reference group was participants who rated the risk of e-cigarettes. 
We repeated the regression to look at between-subjects differences in perceived risk of 
developing heart disease and oral cancer. Preliminary analyses confirmed that randomization 
succeeded in producing groups that did not differ with respect to demographic variables and 
key study variables (e.g., those who were randomly assigned to answer questions about e-
cigarettes did not differ from those who answered about snus).
We also examined the demographic and behavioral variables listed in Table 1 as potential 
correlates of the composite perceived risk measure for e-cigarettes, using bivariate linear 
regressions. We included variables with statistically significant bivariate relationships to 
perceived risk in a simultaneous multivariate linear regression model.
Analyses were run in Stata Version 12. Frequencies are unweighted. Percentages and all 
other analyses used the “svy” command and post-stratification weights to adjust for the 
representativeness of the sample compared to the US population and the sampling design, 
including the combination of probability and non-probability samples. We report 
standardized regression coefficients as betas (β). Statistical tests were two-tailed with a 
critical alpha of .05.
Results
Of current smokers (n = 6,607) in our sample, most were non-Hispanic White (69 %) (Table 
1). About half were female (51 %), had at least some college education (47 %), and had an 
annual household income over $50,000 (45 %). The mean age was 44 (SD 15, range 18–94). 
Half had tried e-cigarettes at least once, and 21 % currently used them. Only 6 % had ever 
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tried dissolvable tobacco products. Most respondents intended to quit smoking cigarettes in 
the next year (54 %) or more than 1 year from now (15 %).
Comparison of e-cigarettes to cigarettes (Hypothesis 1)
Participants perceived e-cigarettes as less likely to cause lung cancer (mean difference 1.17 
between values for e-cigarettes and cigarettes, p < .001), heart disease (1.07, p < .001), and 
oral cancer (1.04, p < .001) compared to regular cigarettes (Fig. 1). The belief that e-
cigarettes were less harmful than regular cigarettes was robust. It persisted in each tested 
demographic subgroup, all p < .001: men (mean difference 1.09 between values for e-
cigarettes and regular cigarettes), women (1.10), high school or less education (1.20), some 
college or more education (0.96), non-Hispanic Whites (1.06), non-Hispanic Blacks (1.56), 
non-Hispanics of other or multiple races (0.78), Hispanics (0.91), those with household 
incomes below $50,000 (1.14), and those with household incomes of $50,000 or more 
(1.03). It also persisted among smokers who plan to quit in the next year (1.25), smokers 
who plan to quit more than 1 year from now (1.05), smokers who do not plan to quit (0.86), 
ever users of e-cigarettes (1.06), and never users of e-cigarettes (1.09). The pattern was the 
same for each individual health condition. That is, for every subgroup, participants in that 
group believed that e-cigarettes were less likely to cause lung cancer, less likely to cause 
heart disease, and less likely to cause oral cancer than cigarettes (all comparisons p < .001).
Comparison of alternative non-cigarette tobacco products to cigarettes (Hypothesis 2)
Participants believed that smokeless tobacco was less likely to cause lung cancer than 
cigarettes (mean difference 0.51 between values for smokeless tobacco and cigarettes, p < .
001), equally likely to cause heart disease (0.06, p = .13), and more likely to cause oral 
cancer (0.61, p < .001) (Fig. 1). Similarly, compared to cigarettes, participants perceived 
snus as less likely to cause lung cancer (0.58, p < .001), equally likely to cause heart disease 
(0.07, p = .14), and more likely to cause oral cancer (0.58, p < .001). Participants also 
believed that dissolvable tobacco was less likely to cause lung cancer (0.54, p < .001) and 
more likely to cause oral cancer (0.27, p < .001) than cigarettes, but they believed that 
dissolvable tobacco was less likely to cause heart disease compared to regular cigarettes 
(0.17, p < .001).
Comparisons of e-cigarettes and alternative non-cigarette tobacco products (exploratory 
between-groups analysis)
Smokers who were randomly assigned to answer items about e-cigarettes believed that they 
were less likely to develop lung cancer from using that product than did smokers who were 
randomly assigned to answer items about using smokeless tobacco, snus, or dissolvable 
tobacco (mean differences 0.57, 0.58, and 0.74, respectively; all between-groups 
comparisons p < .001) (Fig. 1; Table 2). They similarly perceived greater likelihood of 
developing heart disease from other non-combustible products than from e-cigarettes (mean 
differences 0.97 for smokeless tobacco, 0.98 for snus, and 1.08 for dissolvable tobacco; all 
comparisons p < .001). Smokers who were randomly assigned to answer items about 
smokeless tobacco, snus, and dissolvable tobacco believed they were more likely to develop 
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cause oral cancer than smokers who answered about e-cigarettes (mean differences 1.59, 
1.58, and 1.44, respectively; all comparisons p < .001).
Correlates of perceived risks of e-cigarette use
Multivariate analysis of perceived risks of e-cigarette use found that women perceived 
themselves as more likely to develop health problems from using e-cigarettes (β = 0.11, p < .
01) than men (Table 3). Compared to non-Hispanic whites, non-Hispanic participants of 
other or multiple races believed themselves to be more at risk from using e-cigarettes (β = 
0.08, p < .05), as did Hispanic participants (β = 0.14, p < .01). Neither intention to quit 
smoking, nor use of e-cigarettes, was associated with perceptions of the health risks of e-
cigarettes.
Discussion
As use of e-cigarettes increases, it is important to better understand what people think about 
the potential harms of using e-cigarettes relative to cigarettes and other NCTPs. Our national 
study found that smokers believed that regular cigarettes were more likely than e-cigarettes 
to cause lung cancer, oral cancer, and heart disease. In contrast, smokers’ beliefs about the 
harms of the other three NCTPs relative to cigarettes varied by health condition. Comparing 
across groups, we observed that smokers saw e-cigarettes as less risky than the other 
NCTPs.
The finding that smokers believed that e-cigarettes were less likely to cause health problems 
than regular cigarettes supports our first hypothesis. We expect that that this belief reflects 
factors that are specific to e-cigarettes (e.g., advertising) as well as factors that relate more 
generally to new and innovative products. Exposure to pro-e-cigarette messages could drive 
the impression that e-cigarettes are safer than cigarettes. Indeed, two of the most common 
ways that current smokers report learning about e-cigarettes are e-cigarette users and 
advertisements on television, both of which likely highlight the advantages of the product 
(Pepper et al., 2014; Zhu et al., 2013). Positive messages about e-cigarettes also appear 
regularly on YouTube (Paek et al., 2013) and in online ads (Cobb et al., 2013; Grana & 
Ling, 2014). E-cigarettes’ status as an innovative product might reinforce their positive 
characteristics. Rogers’ diffusion of innovation model suggests that smokers might hold a 
positive view about e-cigarettes’ level of harm because the product is novel and thus 
perceived to have relative advantages (e.g., reduced health risk) over cigarettes, the product 
they are replacing (Rogers, 2003). Snus and dissolvable tobacco, although also innovative, 
may be too different from cigarettes for smokers to consider them a replacement. Thus 
smokers may not hold consistent views that these products were less harmful than cigarettes. 
Such misperceptions suggest that participants did not understand the role of combustion in 
creating smoking-related harms (Hecht, 2003; Levy et al., 2004; Royal College of 
Physicians, 2007). If participants had understood this, they would have described all four 
NCTPs as less harmful than regular cigarettes for all health conditions.
The finding that participants believed that snus and dissolvable and smokeless tobacco were 
more likely to cause oral cancer than cigarettes, although this is not objectively true (Royal 
College of Physicians, 2007), supports our second hypothesis. We speculate that the belief 
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derives from the products’ mode of nicotine delivery and the physical act of use. In a 2010 
focus group study, young adults expressed particular concern about snus and dissolvable 
tobacco because those products come in direct contact with the mouth, and thus they 
perceived them to be likely to cause oral cancer and gastrointestinal disease (Choi et al., 
2012). People also place traditional smokeless tobacco directly in their mouths, so they 
might perceive it to have similar harms. Additional support for our second hypothesis, that 
mode of nicotine delivery affects perceived health risk, comes from the finding that smokers 
also viewed regular cigarettes as more likely to cause lung cancer than oral cancer. 
Respondents may have perceived that cigarettes’ primary mode of contact, unlike snus, 
dissolvable tobacco, or smokeless tobacco, is inhaled smoke. That smokers viewed 
smokeless tobacco, snus, and regular cigarettes as equally likely to cause heart disease is 
consistent with this hypothesis; mode of tobacco administration has no intuitive connection 
to the heart.
Our exploratory analysis, based on between-group comparisons, found that smokers 
perceived e-cigarettes to be less harmful than snus, dissolvable tobacco, and smokeless 
tobacco. A recent survey of university students reported similar findings, although the report 
did not explicitly test these comparisons (Latimer et al., 2013). The perceived differences 
between e-cigarettes and the alternative NCTPs may reflect exposure to positive messages in 
increasingly prevalent e-cigarette marketing (Kim et al., 2014).
We found variation in individuals’ beliefs about e-cigarettes’ healthfulness. Women 
believed that e-cigarettes were more likely to cause health problems than did men. Women 
perceive themselves to be at higher risk of developing smoking-related cancer (Oncken et 
al., 2005), perhaps because men are socialized to see themselves as invulnerable (Courtenay, 
2011). Non-Hispanic Whites perceived themselves at lower risk of experiencing health 
problems from e-cigarettes than did some other racial and ethnic groups. These differences 
could reflect participants’ recognition that racial and ethnic minorities are more likely to die 
from some tobacco-related illnesses than non-His-panic Whites (American Cancer Society, 
2013).
Past use of e-cigarettes and intention to quit smoking were not related to beliefs about the 
riskiness of e-cigarettes, but we cannot conclude that these variables are unrelated. Only 
longitudinal or experimental studies can confirm a behavior motivation hypothesis (Brewer 
et al., 2004), in this case that e-cigarette risk perceptions cause a change in e-cigarette use. 
Another potential limitation is that our study asked about cancer and heart disease, but not 
other conditions like emphysema, and only used single item measures of risk for each 
illness. Finally, the combination of probability and non-probability samples is a potential 
limitation, although the large probability sample helped us to properly weight data from the 
non-probability sample. In spite of these limitations, the data present a clear picture that 
smokers perceive the health risks of e-cigarettes to be lower than both traditional and 
alternative tobacco products.
Our findings suggest several avenues for public health and regulatory action. First, most 
participants incorrectly believed that snus, dissolvable tobacco, and traditional smokeless 
tobacco were more likely to cause oral cancer than cigarettes. Thus, smokers who are unable 
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or unwilling to quit smoking might avoid switching to these smokeless products, when in 
fact switching to these products would be a potential harm reduction strategy. Public health 
messages should communicate accurate information about the utility of smokeless tobacco 
as a harm reduction option, although such messages will need to be extremely careful not to 
encourage switching over quitting or inadvertently “selling” smokeless tobacco to non-
smokers. Second, although most participants correctly perceived that e-cigarettes are 
generally less harmful than cigarettes, their ratings of the risks of using e-cigarettes may not 
be accurate. Public health education campaigns will need to stay up to date with the 
changing products and latest research on their health effects in order to keep the public 
informed.
Third, understanding beliefs about the health risks of e-cigarettes could assist with future 
smoking cessation interventions. Should studies show that using e-cigarettes aids smoking 
cessation, drawing attention to the comparison of their health risks to those of regular 
cigarettes could be a valuable intervention approach for encouraging cessation. Finally, the 
US Food and Drug administration is in the process of shaping new regulations for e-
cigarettes and dissolvable tobacco (Food and Drug Administration, 2014), including 
warning labels. By codifying smokers’ beliefs about the health risks of these products, this 
study’s findings could inform the development of labels that clarify or correct perceptions.
The widespread belief that e-cigarettes are less harmful than other products may be one of 
the key factors driving their rise in popularity. Other factors include e-cigarettes’ ability to 
deliver nicotine efficiently (Vansickel & Eissenberg, 2013) and mimic some aspects of the 
physical experience of smoking (Barbeau et al., 2013), as well as the wide variety of 
available flavors (Farsalinos et al., 2013) and personalization options (Brown & Cheng, 
2014; McQueen et al., 2011). Should harm perceptions, in harmony with these and other 
factors, play an important role in popularizing e-cigarettes, our findings suggest that use of 
alternative non-cigarette tobacco products, including novel ones like snus and dissolvable 
tobacco, are unlikely to increase in the same manner as e-cigarettes. While using non-
combustible tobacco is less risky than cigarette smoking, few data exist on the short- and 
long-term health effects of e-cigarettes in particular. Additional research is needed to 
quantify both the absolute risk of using e-cigarettes, as well as the risk of using e-cigarettes 
relative to that of smoking cigarettes.
The context of e-cigarette research and public health practice is changing because e-cigarette 
technology is advancing rapidly. Compared to first-generation models, newer models often 
have “tanks” that can hold more e-liquid, larger rechargeable batteries, and the option to 
“drip” e-liquid directly onto the atomizer instead of using a cartridge (Brown & Cheng, 
2014). Variations in design affect how the product is used (Brown & Cheng, 2014) as well 
as its safety profile (Kosmider et al., 2014). Thus it is important to consider whether 
perceptions of risk vary by product type and are sensitive to actual differences in health risks 
related to product design. Future research should also investigate the impact of exposure to 
e-cigarette advertising and other media on beliefs about e-cigarettes’ harm, how beliefs 
about e-cigarettes’ harm change over time, and whether those beliefs affect smokers’ 
trajectories of e-cigarette and regular cigarette use. Such research could help the public 
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health community identify and deliver appropriate messages about e-cigarettes’ safety and 
inform future product regulation.
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Table 1
Sample characteristics (n = 6,607 current smokers)
Characteristic n Weighted (%)
Respondent
Gender
 Male 2,654 48.8
 Female 3,953 51.2
Age [mean (SD)] 44.2 (15.2)
Education
 Less than high school 365 9.9
 High school 1,777 42.9
 Some college 2,976 34.0
 Bachelor’s degree or higher 1,489 13.2
Race/ethnicity
 Non-Hispanic White 5,179 68.7
 Non-Hispanic Black 535 12.6
 Non-Hispanic, other/multiple 412 6.3
 Hispanic 481 12.4
Employment
 Working 3,380 53.6
 Not working: laid off or looking for work 855 14.2
 Not working: retired, disabled, or other 2,372 32.2
Intention to quit smoking
 In the next year 3,683 53.7
 More than 1 year from now 918 15.0
 Do not plan to quit 2,006 31.3
E-cigarette awareness and use
 Not aware 296 5.1
 Aware but never tried 2,969 44.7
 Former user 1,876 29.4
 Current user 1,466 20.9
Dissolvable tobacco awareness and use
 Not aware 4,667 71.2
 Aware but never used 1,493 22.5
 Have used 447 6.3
Household
Region
 Midwest 1,657 24.3
 Northeast 1,123 17.4
 South 2,305 39.9
 West 1,522 18.4
Household income
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Characteristic n Weighted (%)
 < $25,000 2,038 29.2
 $25,000–$49,999 1,983 26.4
 $50,000–$74,999 1,313 19.1
 $75,000–$99,999 687 14.9
 $100,000 or more 586 10.5
Percentages are weighted, and n’s are unweighted
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Table 2




Smokeless tobacco 2.46 (1.27) 0.19***
Snus 2.47 (1.30) 0.20***
Dissolvable tobacco 2.63 (1.33) 0.25***
Heart disease
E-cigarettes 1.90 (1.04)
Smokeless tobacco 2.87 (1.26) 0.32***
Snus 2.88 (1.27) 0.33***
Dissolvable tobacco 2.98 (1.27) 0.35***
Oral cancer
E-cigarettes 1.89 (1.03)
Smokeless tobacco 3.48 (1.22) 0.50***
Snus 3.47 (1.22) 0.50***
Dissolvable tobacco 3.33 (1.26) 0.45***
Higher mean scores indicate higher perceived likelihood of a health problem (1 = not at all likely—5 = extremely likely)
***
p < .001
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Table 3
Correlates of perceived risk of using e-cigarettes (n = 1,669)
Characteristic Mean (SD) Bivariate β Multivariate β
Respondent
Gender
 Male (ref) 1.80 (0.86)
 Female 2.00 (1.22) 0.10* 0.11**
Age −0.07
Education
 Less than high school (ref) 1.96 (0.85)
 High school 1.85 (0.76) −0.05
 Some college 1.93 (1.21) −0.01
 Bachelor’s degree or higher 1.93 (1.49) −0.01
Race/ethnicity
 Non-Hispanic White (ref) 1.83 (1.08)
 Non-Hispanic Black 1.83 (0.85) −0.00 0.00
 Non-Hispanic, other/multiple 2.15 (1.12) 0.07* 0.08*
 Hispanic 2.27 (0.85) 0.13** 0.14**
Employment
 Working (ref) 1.94 (0.97)
 Not working: laid off or looking for work 1.93 (1.16) −0.00
 Not working: retired, disabled, or other 1.82 (1.08) −0.06
Intention to quit smoking
 In the next year (ref) 1.81 (0.97)
 More than 1 year from now 1.97 (1.12) −0.06
 Do not plan to quit 1.79 (0.91) −0.08
E-cigarette awareness and use
 Not aware or never used (ref) 1.86 (0.99)
 Former user 1.89 (0.99) 0.01
 Current user 1.99 (1.22) 0.05
Household
Region
 Midwest (ref) 1.90 (1.03)
 Northeast 1.81 (0.94) −0.04
 South 1.88 (0.97) −0.01
 West 2.03 (1.26) 0.05
Household income
 < $25,000 (ref) 1.89 (1.16)
 $25,000–$49,999 1.97 (1.13) 0.04
 $50,000 –$74,999 1.89 (0.96) 0.00
 $75,000–$99,999 1.72 (0.80) −0.06
 $100,000 or more 2.00 (1.00) 0.04
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